Clinical Trial Update: Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ospemifene to conjugated estrogens for postmenopausal sexual dysfunction was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Dysfunction Postmenopausal

Drugs mentioned

• Conjugated Estrogens (ESTROGENS, CONJUGATED)
• Ospemifene (ospemifene)

Snippet

Sponsor: Emory University | Conditions: Sexual Dysfunction, Physiological | Phase 4 | Status: TERMINATED | Results posted: 2017-12-20